Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile. / Hansen, Malte Rosager; Ankersen, Dorit Vedel; Marker, Dorte; Carlsen, Katrine; Bennedsen, Mette; Fjordside, Eva; Peters-Lehm, Charlotte Teglgaard; Wewer, Vibeke; Munkholm, Pia; Burisch, Johan.

I: Ugeskrift for Laeger, Bind 182, Nr. 8, V10190588, 2020.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hansen, MR, Ankersen, DV, Marker, D, Carlsen, K, Bennedsen, M, Fjordside, E, Peters-Lehm, CT, Wewer, V, Munkholm, P & Burisch, J 2020, 'Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile', Ugeskrift for Laeger, bind 182, nr. 8, V10190588. <https://ugeskriftet.dk/files/scientific_article_files/2020-02/v10190588_0.pdf>

APA

Hansen, M. R., Ankersen, D. V., Marker, D., Carlsen, K., Bennedsen, M., Fjordside, E., Peters-Lehm, C. T., Wewer, V., Munkholm, P., & Burisch, J. (2020). Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile. Ugeskrift for Laeger, 182(8), [V10190588]. https://ugeskriftet.dk/files/scientific_article_files/2020-02/v10190588_0.pdf

Vancouver

Hansen MR, Ankersen DV, Marker D, Carlsen K, Bennedsen M, Fjordside E o.a. Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile. Ugeskrift for Laeger. 2020;182(8). V10190588.

Author

Hansen, Malte Rosager ; Ankersen, Dorit Vedel ; Marker, Dorte ; Carlsen, Katrine ; Bennedsen, Mette ; Fjordside, Eva ; Peters-Lehm, Charlotte Teglgaard ; Wewer, Vibeke ; Munkholm, Pia ; Burisch, Johan. / Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile. I: Ugeskrift for Laeger. 2020 ; Bind 182, Nr. 8.

Bibtex

@article{eb8d73b9043e4d1e8d760f31fb3ba2a0,
title = "Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile",
abstract = "Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic relapsing diseases with major impact on the patients' everyday life, and increasing incidences affect the burden on the healthcare system. This review summarises the evidence of telemedicine applications (TA) to patients suffering from IBD and IBS in Denmark and abroad. TA have been shown to: reduce time-to-remission, increase quality of life and medical adherence, and reduce hospital admissions and outpatient visits in adult patients with IBD. In paediatric patients with IBD, TA have been shown to reduce: the need of outpatient visits, the number of school absences, and the symptom scores.",
author = "Hansen, {Malte Rosager} and Ankersen, {Dorit Vedel} and Dorte Marker and Katrine Carlsen and Mette Bennedsen and Eva Fjordside and Peters-Lehm, {Charlotte Teglgaard} and Vibeke Wewer and Pia Munkholm and Johan Burisch",
year = "2020",
language = "Dansk",
volume = "182",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "8",

}

RIS

TY - JOUR

T1 - Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile

AU - Hansen, Malte Rosager

AU - Ankersen, Dorit Vedel

AU - Marker, Dorte

AU - Carlsen, Katrine

AU - Bennedsen, Mette

AU - Fjordside, Eva

AU - Peters-Lehm, Charlotte Teglgaard

AU - Wewer, Vibeke

AU - Munkholm, Pia

AU - Burisch, Johan

PY - 2020

Y1 - 2020

N2 - Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic relapsing diseases with major impact on the patients' everyday life, and increasing incidences affect the burden on the healthcare system. This review summarises the evidence of telemedicine applications (TA) to patients suffering from IBD and IBS in Denmark and abroad. TA have been shown to: reduce time-to-remission, increase quality of life and medical adherence, and reduce hospital admissions and outpatient visits in adult patients with IBD. In paediatric patients with IBD, TA have been shown to reduce: the need of outpatient visits, the number of school absences, and the symptom scores.

AB - Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic relapsing diseases with major impact on the patients' everyday life, and increasing incidences affect the burden on the healthcare system. This review summarises the evidence of telemedicine applications (TA) to patients suffering from IBD and IBS in Denmark and abroad. TA have been shown to: reduce time-to-remission, increase quality of life and medical adherence, and reduce hospital admissions and outpatient visits in adult patients with IBD. In paediatric patients with IBD, TA have been shown to reduce: the need of outpatient visits, the number of school absences, and the symptom scores.

M3 - Tidsskriftartikel

C2 - 32138819

VL - 182

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 8

M1 - V10190588

ER -

ID: 260056970